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low-now oxygen therapy
devices
Excluding anaesthetic circuits and
hyperbaric oxygen chambers,
oxygen therapy devices are
classified as high-flow or low-flow
systems (O'Connor and Vender
1995, Oh and Duncan 1988). High-
flow systems deliver a consistent
fraction of inspired oxygen
concentrations (Fi02) as the
oxygen flow rate is sufficient to
meet or exceed the patient's
inspiratory volume and peak
inspiratory flow rate (PI FR).
II pulmonary function (breath
sounds and chest wall
symmetry),
II adequacy of respiration and
normal parameters of
respiration (Sp02/Sa02),
II ventilation (respiratory rate and
depth, PaC02),
II signs and symptoms of therapy-
related complications (ie
pressure sores on the nares
or around the base of nose,
excessive drying of mucous
membranes of the upper
airway),
II cardiac function (heart rate and
blood pressure),
II co-morbidities or medications
that may effect respiratory
function, eg chronic obstructive
airways disease, narcotic
analgesics or anaesthetic agents.
II conscious state,
oxygen from being given to a
hypoxaerriic patient.
When caring for a patient receiving
oxygen it is important to assess
their:
II shortness of breath (dyspnoea),
II alteration in respiratory rate
(bradypnoea or tachypnoea),
II anxiety and agitation.
Indications for initiating oxygen
therapy (Kallstrom 2002) include:
o hypoxaemia (Sa02 < 90),
o respiratory distress,
II post anaesthesia recovery,
II cardiac and respiratory arrest,
II systemic hypotension (systolic
BP < 100mmHg),
II low cardiac output states
and metabolic acidosis
(HC03- < 18mmol/l).
Administering oxygen does have
some risks (O'Connor and Vender
1995). These comprise, but are not
limited to:
II pulmonary - oxygen toxicity,
absorption atelectasis, C02
retention,
II equipment - device malfunction
or oxygen supply failure,
II occupational- increased fire
hazard.
The incidence and extent of these
risks is not clearly reported in the
literature. In all cases however,
risks associated with oxygen
therapy should never prevent
result in the progressive
deterioration of the patient,
beginning with cell death, and if
prolonged, organ failure and
ultimately body system failure and
death (Considine 2oo5a).
Early clinical signs and symptoms
of hypoxaemia (Considine 2005a)
are:
Principles of low-How
oxygen therapy
Oxygen (02) is a physiologic
requirement for normal cellular
function (energy production
through aerobic metabolism), and
is vital to sustaining human life
(Treacher and Leach 1993). The
normal partial pressure of arterial
oxygen (Pa02) at atmospheric
pressure (760 mmHg) is 80 to 100
mmHg. This equates with a normal
oxygen saturation of ~ 95% when
measured by arterial blood
sampling (Sa02) or by pulse
oximetry (Sp02) (Considine
2005a).
Oxygen therapy is the therapeutic
administration of oxygen to
patients for the treatment or
prevention of hypoxaemia (low-
blood oxygen levels) or hypoxia
(inadequate oxygen at the cellular
level). A failure to maintain
adequate blood oxygen levels can
lntroducticm
Low-flow oxygen therapy devices
are often the first choice for the
treatment of mild to moderate
hypoxaemia (Sp02 90-95%)
(Pierce 1995). Ensuring that
oxygen is administered in a timely
and appropriate way using the
right device is an important aspect
of patient care. Selecting the right
device can be difficult as there are
a variety to choose from and a lack
of practical information on
selection (Eastwood et al 2004).
This paper provides an overview of
oxygen therapy principles,
describing the indications and care
requirements of three low-flow
oxygen therapy devices and
providing an algorithm for
managing refractory hypoxaemia.
visible just below the soft palate.
The catheter is secured in position
by an adhesive dressing or tape
placed on the patient's cheek.
Oxygen tubing is then connected
to the distal end of the catheter.
Oxygen flow rates are adjusted
to meet target blood oxygen
concentrations (Sp02/Sa02)
(Eastwood and Dennis 2006).
Care requirements for NPO
therapy:
~ ensure catheter is placed correctly
(tip just visible below the soft
palate when mouth open),
e removal of catheter for cleaning
with sterile water 12-24 hourly
(to reduced the risk of
obstruction),
e use oxygen flow rates::;; 6 Llmin,
e observe for catheter related
pressure on the nares, drying of
the back of the throat, and
bleeding from the nose
(Eastwood and Dennis 2006).
Nasal prongs
Nasal prongs (also known as nasal
cannula or nasal spectacles)
consist of two short tapered
prongs (about 1 cm in length).
Nasopharyngeal
oxygen catheters
Nasopharyngeal oxygen therapy
(NPO) is the delivery of
supplemental oxygen directly into
the nasopharynx via an oxygen
catheter (size 10 FG for adults)
(Eastwood et al 2004, Frey and
Shann 2003). When positioned
correctly the tip of the catheter is
alternative to these two devices
is the use of oxygen catheters to
achieve nasopharyngeal oxygen
therapy (N PO) in adult patients
(Eastwood and Dennis 2006,
Eastwood et aI2004). A
description and list of care
requirements for NPO therapy:
NP, and FM is provided below.
A comparison of these devices is
shown in table 1 below.
Other low-flow oxygen devices
such as partial rebreather masks
and non-rebreather masks have
been excluded from this paper as
they are typically used to treat
more severe forms of hypoxaemia
and often require specialised
nursing knowledge and care
during their use. Each device will
now be described in detail with its
accompanying nursing care.
Low-flow systems also deliver a
variable Fi02 because of changes
in ventilatory pattern (tidal volume,
respiratory rate, and PI FR); the
entrainment of room air in order
to meet inspiratory volume and;
device-related characteristics
such as shape and oxygen flow
capabilities (Barnes 2000,
O'Connor and Vender 1995,
Calianno et aI1995).
Low-flow oxygen therapy devices
are generally used in patients with
minimal respiratory distress,
adequate ventilatory patterns but
still require supplemental oxygen
for therapeutic reasons (Calianno
et a11995, Oh and Duncan 1988).
low-flow oxygen therapy devices
are generally easily accessible and
often the first choice for the
treatment of mild to moderate
hypoxaemia (Sp02 90-95%).
Low-flow oxygen devices are still
capable of providing high Fi02
if a patient was to have a slow,
shallow ventilatory pattern
(O'Connor and Vender 1995).
Two of the most commonly used
low-flow oxygen therapy devices
are nasal prongs (NP) and simple
face masks (FM). An emerging
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Each prong lies approximately 1 cm
within each nostril. Tubing of the
nasal prongs is looped over the
ears and secured under the chin.
Oxygen tubing of the nasal prongs
is then connected to an oxygen
outlet (McConnell 1996). Oxygen
flows are adjusted to meet target
blood oxygen concentrations
(Sp02/Sa02). They are relatively
cheap, easy to apply, and generally
tolerated well by patients. They
rarely interfere with a patient's
ability to eat, talk, sleep and cough
(Costello et a1199S, Fairfield et al
1991, Stewart and Howard 1990).
However they can be easily
dislodged, which may result in an
unacceptable drop in blood oxygen
levels (Hess et aI1984).
Care requirements for nasal
prongs:
• ensure nasal prongs are
correctly placed (prong in each
nostril) and secured,
III be vigilant for prong
dislodgement or displacement,
• observe for catheter related
pressure on the nares, drying of
the back of the throat, and
bleeding from the nose
(McConnell 1996).
Simple face masks
Simple face masks are half-pear
shaped, made of plastic, and worn
over the nose and mouth (Barnes
2000). Mask strapping is tightened
around the patient's head to
ensure a secure fit. Oxygen tubing
is then connected from the mask
to the oxygen outlet. Administered
oxygen flow rates are faster than
that of NPO or NP therapy. Face
mask oxygen therapy however can
induce claustrophobic sensations
in some patients; cause drying of
the mouth and nose; hinder the
passage of vomitus and; require
removal for eating and drinking
(Eastwood and Dennis 2006).
Care requirements for FM:
• ensure mask is fitted correctly
(covering nose and mouth),
e maintain oxygen flow rates> 6
L/min (to limit carbon dioxide
re-breathing),
• be watchful for the frequent
removal of the mask by the
patient,
e observe for device-related
complications such as the
development of pressure areas
on the bridge of the nose or skin
irritation around the ears
(Nerlich 1997, McConnell 1997).
Selecting the right device
Selecting the right device can lead
to more efficient use of resources
(ie oxygen, oxygen therapy
equipment and nursing time),
treatment tailored to better meet
patient needs, health care cost
savings, and increased patient
satisfaction and compliance with
low-flow oxygen therapy. For
effective oxygen administration
nurses need to select the
appropriate device and oxygen
flow rates.
Several questions can assist in the
process of device selection.
• What low-flow oxygen therapy
devices are available?
• Do I have the knowledge and
skill to effectively use these
devices?
III Will the device selected be able
to meet the patient's oxygen
requirements?
• Are there any patient-related
factors that would prevent a
particular device being used?
e Are there any device-related
factors that would prevent its
use?
• What alternative devices can I
access should the initial device
fail to achieve adequate blood
oxygen levels?
As a guide, NPO therapy should be
considered in patients who require
modest increases in Fi02 but are
unable to wear a FM or to
overcome some of the
disadvantages associated with NP
oxygen therapy (ie that the prongs
can easily dislodge or cause skin
irritation around the ears and
nares). Nasal prongs are for
patients who require small to
modest increases in Fi02, are still
able to eat and talk unhindered, or
find the wearing of a FM
uncomfortable or distressing. Face
masks can be reserved for patients
with greater Fi02 requirements or
temporary abnormal lung
ventilation patterns (ie the
immediate post-operative period).
If a patient finds the experience of
oxygen therapy uncomfortable or
distressing, informing them of the
reason for therapy may provide
reassurance and alleviate concern.
Additionally, it maybe beneficial to
trial a different device and discuss
its comfort, as this may improve
compliance with treatment while
still maintaining satisfactory blood
oxygen levels.
Treatment of refractory
hypoxaemia
Refractory or unresolved
hypoxaemia is potentially life-
threatening. Nurses playa pivotal
role in the management of
hypoxaemic states (Considine
200Sb). Current published
protocols and reviews for oxygen
administration however often fail
to provide practical information to
assist with the selection and use of
oxygen devices (Kallstrom 2002,
Cunningham 1997, Treacher and
Leach 1998, O'Connor and Vender
1995). In response, a five step
practical approach to the
management of refractory
hypoxaemia will now be described
and a treatment plan shown in
table 2 (next page). As well as its
therapeutic benefit managing
refractory hypoxaemia in a
systematic way minimizes the
harmful effects of low-blood
oxygen levels.
Step one: identify and treat
underlying cause of hypoxaemia if
possible.
The major causes of hypoxaemia
are hypoventilation, ventilation-
perfusion inequalities, lung
disease, or low Pa02 (as
experienced at high altitude).
Step two: establish a target
Sp02/Sa02.
Because different patients have
different oxygen therapy
requirements it is important to
establish a target Sp02/Sa02 in
consultation with the patient's
treating physician.
It is important to note that within
the group of patients with Chronic
Obstructive Airways Disease
(COAD) who rely on their hypoxic
drive to stimulate breathing;
incorrect administration of
supplemental oxygen can cause
respiratory depression. These
patients require carefully
controlled oxygen therapy with
close monitoring of Sp02 or Pa02
concentrations (Nerlich 1997,
Doyle 1992). Additionally, to
prevent tissue hypoxia there are
clinical conditions where oxygen is
administered in the presence of
normal Pa02/Sa02. These
conditions include myocardial
infarction and carbon monoxide
poisoning (Considine 200S).
Step three: select an appropriate
low-flow oxygen therapy device.
Consider patient-related, nurse-
related, and context specific
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Abbreviations.
Air entrainment mask (AEM); cardiac
output (CO); haemoglobin (Hb); nasal
prong (NP); nasopharyngeal oxygen
(NPO); oxygen (Oz); face mask (FM);
Saturation of arterial oxygen (SaOz);
ventilation/perfusion match (V/Q
match). Adapted from Oxygen Therapy,
Lecture by Dennis M, Z003, School of
Nursing, Deakin University, Victoria.
Oh~ T.
~JV" /i./iedfcal journof of Austrol/o;
i/t 9\ 3) :'.141.-1116.
practice. Until appropriate
guidelines are developed, when
supplemental oxygen is needed,
the simplest, most effective form
of therapy should be given.
References
Achieving the target Sp02/Sa02
concentration is the fundamental
determinant of therapy
effectiveness. Effectiveness may
also be measured for the patient in
terms of comfort and compliance
with therapy; the nurse in terms of
time and user-friendliness; and for
the hospital in terms of cost and
use.
Nurses make decisions every day
regarding the selection and
management of low-flow oxygen
therapy devices. Improvements in
the selection process however are
warranted. The development and
implementation of clinical practice
guidelines supported by best
available evidence has the
potential to improve this aspect of
factors that may impact on the
administration of oxygen.
Step four: fit device and adjust
oxygen flow rates to achieve target
Sp02/Sa02.
Correct fit and patient education
for the reasons of oxygen therapy
is essential to optimising effective
oxygen therapy. Adjuncts to
oxygen therapy include:
• optimum patient positioning,
• analgesia,
• patient education, and
41 chest physiotherapy.
Step five: evaluate oxygen therapy
effectiveness.
TABLE 2: TREATMENT PLAN FOR REFRACTORY HYPOXAEMIA
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